Apixaban (Eliquis^®) is a novel oral pyrazole-based direct FXa inhibitor. The title compound is an intermediate in the synthesis of the anticoagulant, Apixaban. X-ray powder diffraction data for the title compound, are reported [a = 9.511(5) Å, b = 18.539(2) Å, c = 5.645(3) Å, α = 90°, β = 101.813(1)°, γ = 90°, unit-cell volume V = 974.28 ų, Z = 2, ρ_cal = 1.336 g cm⁻³, and space group P2]. All measured lines were indexed and are consistent with the P2 space group. No detectable impurities were observed.